Notizie AIOM – anno XV
CHMP Recommends Approval of Maintenance Lenalidomide in Post-ASCT Myeloma
January 28th, 2017 - The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of lenalidomide as a maintenance therapy following autologous stem cell transplant (ASCT) for patients with newly diagnosed multiple myeloma, according to ...Leggi tutto
American Society of Clinical Oncology Policy Brief: FDA’s Regulation of Electronic Nicotine Delivery Systems and Tobacco Products
Since the release of the first Surgeon General’s report on Smoking and Health in 1964 and subsequent Surgeon General’s reports that have implicated an increasing number of malignancies and other adverse health effects caused by smoking, the federal government ...Leggi tutto
Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer
Recent studies have suggested associations between statins and enhanced survival among patients with pancreatic ductal adenocarcinoma (PDAC). However, the relationship between statins, cholesterol, and survival remains unclear. We conducted a retrospective cohort study on ...Leggi tutto
Immuno-Oncology: There’s More to Discover. A white paper for the multidisciplinary cancer care team
Today, the potential of immunotherapy is being realized as a chief pillar of oncology treatment. From the fi rst cytokine therapy approval by the U.S. Food and Drug and Administration (FDA) in 1986, followed by approval for a prostate cancer cell therapy/vaccine, and ...Leggi tutto
Factors Associated With Early Discontinuation of Study Treatment in the Mammary Prevention.3 Breast Cancer Chemoprevention Trial
Aromatase inhibitors are established breast cancer chemoprevention interventions. However, nonadherence remains a significant challenge. We investigated the association between worsening menopause-specific quality of life, baseline participant characteristics, and early ...Leggi tutto